Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy

Gregory M Lucas, B. Anna Mullen, Mary Elizabeth McCaul, Paul J. Weidle, Shannon Hader, Richard D Moore

Research output: Contribution to journalArticle

Abstract

Supervised dosing is a cornerstone of tuberculosis treatment. HIV treatment strategies that use directly administered antiretroviral therapy (DAART) are increasingly being assessed. In a prospective single-arm clinical trial, we enrolled methadone-maintained, HIV-infected participants to receive supervised doses of antiretroviral therapy (ART) on days when they received methadone. Other ART doses were self-administered. In this analysis we examined factors associated with retention to DAART, adherence to supervised doses, and virologic failure. Factors associated with retention to DAART were assessed with the Kaplan-Meier method and Cox proportional hazards models. Factors associated with nonadherence with supervised dosing and with virologic failure were assessed by logistic regression and techniques for longitudinal data analysis. A total of 16,453 supervised doses were administered to 88 participants over a median follow-up of 9.4 months. The median participant adherence with supervised dosing was 83%. Active drug use, determined by urine drug screens, was associated twofold increased risks of both intervention dropout and nonadherence with supervised doses. Adherence with supervised doses was strongly associated with virologic failure. Because DAART was administered only on methadone dosing days, fewer than half of the total ART doses were scheduled to be supervised in most participants. The percent of doses that was scheduled to be supervised was not associated with either adherence or with virologic failure. Given that a relatively small proportion of the total ART doses were supervised in many patients, future studies should assess how DAART affects adherence with nonsupervised doses and retention to ART.

Original languageEnglish (US)
Pages (from-to)564-574
Number of pages11
JournalAIDS Patient Care and STDs
Volume21
Issue number8
DOIs
StatePublished - Aug 2007

Fingerprint

Methadone
Treatment Failure
Pharmaceutical Preparations
Therapeutics
HIV
Proportional Hazards Models
Statistical Factor Analysis
Tuberculosis
Logistic Models
Clinical Trials
Urine

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Leadership and Management
  • Nursing(all)

Cite this

Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy. / Lucas, Gregory M; Mullen, B. Anna; McCaul, Mary Elizabeth; Weidle, Paul J.; Hader, Shannon; Moore, Richard D.

In: AIDS Patient Care and STDs, Vol. 21, No. 8, 08.2007, p. 564-574.

Research output: Contribution to journalArticle

@article{6d9e3e34d2b2469bbebd140d70fe5a24,
title = "Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy",
abstract = "Supervised dosing is a cornerstone of tuberculosis treatment. HIV treatment strategies that use directly administered antiretroviral therapy (DAART) are increasingly being assessed. In a prospective single-arm clinical trial, we enrolled methadone-maintained, HIV-infected participants to receive supervised doses of antiretroviral therapy (ART) on days when they received methadone. Other ART doses were self-administered. In this analysis we examined factors associated with retention to DAART, adherence to supervised doses, and virologic failure. Factors associated with retention to DAART were assessed with the Kaplan-Meier method and Cox proportional hazards models. Factors associated with nonadherence with supervised dosing and with virologic failure were assessed by logistic regression and techniques for longitudinal data analysis. A total of 16,453 supervised doses were administered to 88 participants over a median follow-up of 9.4 months. The median participant adherence with supervised dosing was 83{\%}. Active drug use, determined by urine drug screens, was associated twofold increased risks of both intervention dropout and nonadherence with supervised doses. Adherence with supervised doses was strongly associated with virologic failure. Because DAART was administered only on methadone dosing days, fewer than half of the total ART doses were scheduled to be supervised in most participants. The percent of doses that was scheduled to be supervised was not associated with either adherence or with virologic failure. Given that a relatively small proportion of the total ART doses were supervised in many patients, future studies should assess how DAART affects adherence with nonsupervised doses and retention to ART.",
author = "Lucas, {Gregory M} and Mullen, {B. Anna} and McCaul, {Mary Elizabeth} and Weidle, {Paul J.} and Shannon Hader and Moore, {Richard D}",
year = "2007",
month = "8",
doi = "10.1089/apc.2006.0192",
language = "English (US)",
volume = "21",
pages = "564--574",
journal = "AIDS Patient Care and STDs",
issn = "1087-2914",
publisher = "Mary Ann Liebert Inc.",
number = "8",

}

TY - JOUR

T1 - Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy

AU - Lucas, Gregory M

AU - Mullen, B. Anna

AU - McCaul, Mary Elizabeth

AU - Weidle, Paul J.

AU - Hader, Shannon

AU - Moore, Richard D

PY - 2007/8

Y1 - 2007/8

N2 - Supervised dosing is a cornerstone of tuberculosis treatment. HIV treatment strategies that use directly administered antiretroviral therapy (DAART) are increasingly being assessed. In a prospective single-arm clinical trial, we enrolled methadone-maintained, HIV-infected participants to receive supervised doses of antiretroviral therapy (ART) on days when they received methadone. Other ART doses were self-administered. In this analysis we examined factors associated with retention to DAART, adherence to supervised doses, and virologic failure. Factors associated with retention to DAART were assessed with the Kaplan-Meier method and Cox proportional hazards models. Factors associated with nonadherence with supervised dosing and with virologic failure were assessed by logistic regression and techniques for longitudinal data analysis. A total of 16,453 supervised doses were administered to 88 participants over a median follow-up of 9.4 months. The median participant adherence with supervised dosing was 83%. Active drug use, determined by urine drug screens, was associated twofold increased risks of both intervention dropout and nonadherence with supervised doses. Adherence with supervised doses was strongly associated with virologic failure. Because DAART was administered only on methadone dosing days, fewer than half of the total ART doses were scheduled to be supervised in most participants. The percent of doses that was scheduled to be supervised was not associated with either adherence or with virologic failure. Given that a relatively small proportion of the total ART doses were supervised in many patients, future studies should assess how DAART affects adherence with nonsupervised doses and retention to ART.

AB - Supervised dosing is a cornerstone of tuberculosis treatment. HIV treatment strategies that use directly administered antiretroviral therapy (DAART) are increasingly being assessed. In a prospective single-arm clinical trial, we enrolled methadone-maintained, HIV-infected participants to receive supervised doses of antiretroviral therapy (ART) on days when they received methadone. Other ART doses were self-administered. In this analysis we examined factors associated with retention to DAART, adherence to supervised doses, and virologic failure. Factors associated with retention to DAART were assessed with the Kaplan-Meier method and Cox proportional hazards models. Factors associated with nonadherence with supervised dosing and with virologic failure were assessed by logistic regression and techniques for longitudinal data analysis. A total of 16,453 supervised doses were administered to 88 participants over a median follow-up of 9.4 months. The median participant adherence with supervised dosing was 83%. Active drug use, determined by urine drug screens, was associated twofold increased risks of both intervention dropout and nonadherence with supervised doses. Adherence with supervised doses was strongly associated with virologic failure. Because DAART was administered only on methadone dosing days, fewer than half of the total ART doses were scheduled to be supervised in most participants. The percent of doses that was scheduled to be supervised was not associated with either adherence or with virologic failure. Given that a relatively small proportion of the total ART doses were supervised in many patients, future studies should assess how DAART affects adherence with nonsupervised doses and retention to ART.

UR - http://www.scopus.com/inward/record.url?scp=35448990547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35448990547&partnerID=8YFLogxK

U2 - 10.1089/apc.2006.0192

DO - 10.1089/apc.2006.0192

M3 - Article

C2 - 17711381

AN - SCOPUS:35448990547

VL - 21

SP - 564

EP - 574

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

SN - 1087-2914

IS - 8

ER -